Task: Answer the multiple choice question.
Question: Which drug exhibits a -51.869\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) COc1ccccc1C(=O)N1CCc2ccccc21
b) O=c1oc2cc(O)c(Cl)cc2c2ccccc12
c) Cn1c(CCN2CCCCC2)nc2cc(NC(=O)COc3ccccc3)ccc21
Answer: c. Cn1c(CCN2CCCCC2)nc2cc(NC(=O)COc3ccccc3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(CCN2CCCCC2)nc2cc(NC(=O)COc3ccccc3)ccc21
Cn1c(CCN2CCCCC2)nc2cc(NC(=O)COc3ccccc3)ccc21
N-[1-methyl-2-(2-piperidin-1-ylethyl)benzimidazol-5-yl]-2-phenoxyacetamide